Form 8-K · Current Report · Filed 2024-11-12
Cardinal Health Announces Acquisitions and Financing
Cardinal Health, Inc. announced on November 11, 2024, its intention to acquire a majority stake in GI Alliance for approximately $2.8 billion and Advanced Diabetes Supply Group for approximately $1.1 billion, aiming to accelerate its multi-specialty and at-Home Solutions growth strategies. The company also secured a $2.9 billion bridge loan facility with Bank of America, N.A. for funding these acquisitions. These transactions are expected to be accretive to Cardinal Health's revenue and profit growth starting in the first 12 months following the close, subject to regulatory approvals and customary closing conditions.
- Filer
- Cardinal Health Inc. CAH · NYSE
- Filed
- Accession
- 0001193125-24-255062
- CIK
- 0000721371
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Entry into a Material Definitive Agreement
Regulation FD Disclosure
Financial Statements and Exhibits
Market reaction
Close before filing
$121.64
Next session
+3.0%
Since filing
+89.1%
Latest close
$230.03
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from CAH reporting the same item, with the next session's move:
Exhibits (3)
About Cardinal Health Inc.
Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.
Never miss another CAH filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.